Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Changmao Biochemical Engineering Co. Ltd. Class H ( (HK:0954) ) has issued an update.
Changmao Biochemical Engineering Company Limited has announced that its board of directors will hold a meeting on March 28, 2025. The meeting will address several key issues, including the approval of the audited financial statements for the year ending December 31, 2024, consideration of a final dividend, and the planning of the company’s annual general meeting. This meeting is significant for stakeholders as it will provide insights into the company’s financial health and strategic decisions for the upcoming year.
More about Changmao Biochemical Engineering Co. Ltd. Class H
Changmao Biochemical Engineering Company Limited is a joint stock limited company incorporated in the People’s Republic of China. It operates within the biochemical engineering industry, focusing on the production and distribution of biochemical products.
YTD Price Performance: -6.00%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €24.99M
For detailed information about 0954 stock, go to TipRanks’ Stock Analysis page.